Two medical professionals look at a monitor while standing beside a patient in a bed.

Sections within Internal Medicine

Allergy and Clinical Immunology

Clinical Immunology and Allergy focuses on the diagnosis and management of allergic disorders, asthma, chronic urticaria, angioedema, drug allergy, stinging insect allergy as well as immunodeficiency.

The section is predominantly an out-patient ambulatory care specialty, but we also provide inpatient consultation at all hospitals of the WRHA. Currently we have three physicians with clinics at Health Sciences Centre and Grace Hospital. Interest in Clinical Immunology and Allergy as a career has risen in the past several years. There is high demand for rotations by residents through our RCPS of Canada approved training program. Subspecialty residents, Internal Medicine residents and medical students are involved in a variety of research projects, with presentations at national and international meetings.

Section head:Dr. Christine Peschken

Cardiology

The Section of Cardiology provides leading research, education and patient care opportunities.

Cardiology is one of the largest sections in the department and is home to 30 academic cardiologists and leaders in their field of expertise: 10 echocardiologists, nine interventionalists, five electrophysiologists, four heart failure/transplant specialists, two nuclear medicine cardiologists, four clinician-scientists, one CT/MRI cardiologist, two rehab/lipids cardiologists, nine adult cardiology fellows, 11 admin assistants/secretaries, five transcriptionists, five PTMs, more than 130 RN/CRNs/access coordinators/nurse educators, 12 outpatient clinical unit assistants, 20 echo technicians, 10 x-ray technicians, 61 EKG/Holter/GXT technicians and 11 nuclear techs.

Section of Cardiology clinician-scientists produce 105 publications annually; 200 national/international presentations annually; 30 industry funded clinical trials; six research study nurses; 8.5 million dollars peer reviewed funds.

Section head: Dr. Davinder Jassal

Critical Care

The section originated as part of the Department of Internal Medicine, and remains so today, though the more than 30 intensivists on our faculty come from a variety of departments including Anesthesia, Emergency Medicine, Internal Medicine and Surgery.

We provide critical services for adults in Manitoba, northwestern Ontario and Nunavut. Because of the distances, critical care transport, including specially equipped aircraft, is integral to our clinical work.

We have five Intensive Care Units in two academic/tertiary hospitals; the Winnipeg Health Sciences Centre has a Medical ICU, a Surgical/Trauma ICU, and a Respiratory ICU; St. Boniface Hospital has a Medical-Surgical ICU and a Cardiovascular Surgery ICU. In addition, a community hospital, Grace General Hospital, has a Medical-Surgical ICU.

Intensive Care Units within the city possess advanced support capability including invasive mechanical ventilation, continuous renal replacement therapy and Extra-Corporeal Membrane Oxygenation. Approximately 5000 patients are admitted to our ICUs annually.

The Section of Critical Care Medicine is also active in education, research and outcomes improvement. We provide Critical Care education for medical students, residents and fellows.

Section head: Dr. Bojan Paunovic

Dermatology

The Section of Dermatology consists of three lecturers, two associate professors, three assistant professors, and one professor. Dr. Marni Wiseman’s current activity consists of a collaboration at Cancer Care with Dr. James Johnston; Incidence of Skin Cancer in CLL Patients, Examining Treatment of Patient Immunobullous Disease with Rituximab.

Dermatology has many clinic locations at the physicians’ private locations throughout Winnipeg, as well as St. Boniface General Hospital and Health Sciences Centre, though there are no in-patient units. Currently, there is approximately a $45,000 grant from the Canadian Dermatology Foundation. Dermatology also proudly supports the Teddy Bears' Picnic annually. Further, Dermatology holds a monthly journal club and clinical meeting where patients are presented.

Section head: Dr. Marni Wiseman

Endocrinology and Metabolism

The section has a strong commitment to the provision of clinical services, undergraduate and postgraduate teaching and basic and clinical research.

Our 10 full-time faculty members provide specialized in-patient and out-patient ambulatory care to a wide variety of patients with hormonal and metabolic disorders including those living with Type 1 and Type II Diabetes Mellitus, endocrinology related complications in pregnancies, thyroid cancers, osteoporosis pituitary and reproductive disorders. Section members provide direct patient care via the ambulatory care clinics and through consultative services at the two tertiary care teaching hospitals.

Section members actively participate in undergraduate and postgraduate education. Our postgraduate training program in Endocrinology and Metabolism is a two-year Royal College accredited program in adult endocrinology which is designed to provide the trainee with sufficient exposure to endocrine and metabolic disorders and the necessary clinical and basic science knowledge base to function capably in a consultant capacity in a community or academic setting.

Section head: Dr. Pamela Katz

Gastroenterology

The Section of Gastroenterology is based at the Health Sciences Centre and St. Boniface Hospital in Winnipeg. The section’s experienced and diversified academic clinician-scientists (seven full time and ten affiliated community gastroenterologists) perform clinical services for Manitoba, northwestern Ontario, and Nunavut; coordinate the Emergency Endoscopy On Call service for the WRHA; provide teaching in gastroenterology at the University of Manitoba, and ongoing CME programs for medical professionals; and research into gastrointestinal diseases, including IBD, gastrointestinal cancer, celiac disease, functional disorders, acid peptic disorders and nutritional support. Gastroenterology out-patient care is provided at our ambulatory care clinics located at the two tertiary care centres: Health Sciences Centre and St. Boniface Hospital.

Section head: Dr. Donald Duerksen

General Internal Medicine

The Section of General Internal Medicine (GIM) includes a diverse group of over 40 full-time and part-time faculty members who oversee the major in-patient and out-patient clinical care services at the three major teaching hospitals in Winnipeg.

Our physicians provide clinical attending services in six clinical teaching units, in-patient consult services, and numerous ambulatory care clinics at Winnipeg’s two tertiary care centre and community hospitals. Our ambulatory care clinics offer post-admission follow-ups for patients who were admitted to the internal medicine wards in addition to referrals received from primary care providers for GIM, family physician consults, and referrals and consults from the ER.

Our faculty members actively participate in undergraduate and postgraduate education. The GIM residency program is designed to provide our residents with the broadest clinical experience that will afford them the best opportunity to attain the knowledge, skills and attitudes to become a strong clinical physician and to practice internal medicine in the most exemplary manner.

Section heads: Dr. Patrick Griffin, Dr. Ken Van Ameyde

Geriatric Medicine

The Section of Geriatric Medicine provides a two-year subspecialty residency training program in geriatric medicine accredited by the Royal College of Physicians and Surgeons of Canada. The first eight months of the program are designed to provide the trainee with a strong core of clinical experience in geriatrics.

Section head: Dr. Philip St. John

Hepatology

The Section of Hepatology at the University of Manitoba was the first of its kind in Canada, being independent from gastroenterology. The section’s faculty consists currently of six hepatologists and a PhD researcher. Two clinical assistants and post-doctoral fellows complement the team.

Several sections members are actively involved in clinical research that is conducted through our clinical trial unit with several research nurses. One clinical research focus is liver disease, in particular non-alcoholic fatty liver disease, in Canadian First Nations population for which two section members attracted CIHR funding. One of our faculty is a CIHR funded clinician-scientist with an active lab-based research program on role of cancer stem cells in the pathogenesis of hepatocellular and cholangio-carcinoma.

The section offers a RCPSC AFC program in adult Hepatology and, apart from hepatology fellows, trains rotating fellows and residents from General Internal Medicine and Gastroenterology. In addition all faculty members are involved in UGME training. The section provides clinical services for outpatients and a consult service for inpatients covering all aspects of hepatology including pre and post-transplantation care, and serves as the tertiary hepatology referral center for the Manitoba, Nunavut and NW Ontario.

Section head: Dr. Eberhard Renner

Hematology and Oncology

The Section of Hematology and Oncology, within the Department of Internal Medicine, Max Rady College of Medicine, in affiliation with CancerCare Manitoba (CCMB) as the Department of Medical Oncology and Hematology, CCMB, is a research-oriented group that offers comprehensive care to adults in Manitoba with cancer and serious blood disorders.

The section consists of 34 full-time and five part-time faculty members, of whom 25 are assistant professor, nine associate, and five full professors. Included in our team are three physician assistants (PAs), eight clinical assistants (CAs), and five nurse practitioners (NPs). Our ambulatory care clinical services are based at three CancerCare Manitoba sites in Winnipeg, while in-patient services are at St. Boniface Hospital and Health Sciences Centre, the latter including a unit dedicated to complex hematological malignancy and Blood and Marrow Transplantation (BMT).

We offer two distinct undergraduate courses at the Max Rady College of Medicine: Blood/Immunology and Medical Oncology. We provide Royal College of Physicians and Surgeons of Canada (RCPSC) accredited residency training programs in both Hematology and Medical Oncology, and also offer advanced (post-residency) training in sub-specialties such as BMT, lymphoma and thoracic malignancy. In conjunction with CancerCare Manitoba’s Community Cancer Program, our section members lead annual continuing professional development sessions for primary care practitioners and specialists such as the Community Cancer Program Annual Meeting, Blood Disorders Day and a Geriatric Oncology Day.

The section’s research portfolio is broad, with approximately $10.8 million in active research funding, some 65 peer-reviewed publications per year, and a total of 6.5 physician full-time equivalents dedicated to research. We participate in clinical trials and we lead translational research, and cancer epidemiology and health outcomes programs through our partnership with CCMB’s Research Institute in Hematology/Oncology and the provincial Cancer Registry. High profile research interests include: Chronic Lymphocytic Leukemia (CLL), for which there is an active tumour bank and patient registry; Acute Care Hematology, in which there is close collaboration with critical care partners; studies of the pathogenesis, treatment and prevention of infections in vulnerable cancer patient populations; BMT registry outcomes, based on the Canadian BMT registry that is housed at CCMB.

Section members hold major leadership positions within both Canadian and International organizations, such as the Canadian Partnership Against Cancer (CPAC), pCODR (Pan-Canadian Oncology Drug Review), CBMTG (Canadian Blood and Marrow Transplant Group), ISBER (International Society for Biological and Environmental Repositories), RCPSC, the Infectious Diseases Society of America (IDSA), and ASH (American Society of Hematology).

The Section of Hematology and Medical Oncology’s research portfolio is broad, with approximately $10,800,000 in active research funding, some 65 peer-reviewed publications per year, and a total of six and a half physician full-time equivalent (FTE) dedicated to research. Our researchers are clinical trial leaders, from investigator-initiated local, Canadian, and International trials to large cooperative group trials. Many of our scientists lead translational research programs within the Research Institute in Oncology and Hematology (RIOH, CancerCare Manitoba), such as our chronic lymphocytic leukemia (CLL), acute care hematology (including transfusion, hemorrhage, blood conservation and the hematologic consequences of critical illness), BMT, Lung Cancer, Pancreas Cancer and Brain Cancer Research Clusters. We have a large group of health outcome and clinical epidemiology researchers who leverage Manitoba’s connected datasets – including the Manitoba Cancer Registry, the BMT Registry, Manitoba Health administrative and clinical datasets and the CancerCare Manitoba’s electronic record.


Investigators in the Section of Hematology and Oncology are affiliated and supported by RIOH and collaborate closely with basic scientists (translational, genomic, etc.) and clinical investigators at the Research Institute and at the University of Manitoba.

Aligning with our academic mission, we enthusiastically work with and mentor research trainees at any stage, including BSc(Med), Masters and PhD candidates. In the Department, trainees and junior faculty have the opportunity to be embedded into one of several research clusters, notably the Breast Cancer, CLL or Acute Care Hematology Research Clusters. To acquire formal research training, we encourage interested senior clinical trainees to enroll in local epidemiology and clinical trials training at a Masters of PhD level. The University of Manitoba’s Clinician Investigator Program further offers opportunities for trainees to acquire practice research skills essential to those preparing for careers as Clinician-Scientists. We strongly believe in collaboration and encourage anyone interested to contact us to become involved in hematology and oncology research.

Section head: Dr. Leonard Minuk

Infectious Diseases

The Section of Infectious Diseases of the Department of Internal Medicine, University of Manitoba focuses on patient care, educational, basic and clinical research activities.

Currently, the section consists of nine full-time GFT members but expands to 18 members when cross-appointees and non-GFT’s are included. Adult infectious diseases specialists provide inpatient and outpatient care consultation primarily at Health Sciences Centre and St Boniface General Hospital. ID specialists also oversee the Community IV Antibiotic Clinics as well as other hospitals in Winnipeg, throughout Manitoba, Northern Ontario and Nunavut. Research areas of active interest in the Section of Infectious Diseases include: HIV/AIDS vaccine design epidemiology and pathogenesis, with a global health focus; Nosocomial infections; Antibacterial resistance; Urinary tract infections; Emerging infectious diseases and Indigenous health and community based HIV prevention.

The Subspecialty Training Program in the Infectious Diseases at the University of Manitoba offers a two-year training period. The fellowship program usually admits one to two fellows per year who train closely with pediatric infectious diseases fellows and medical microbiology residents. Opportunities for joint training in infectious diseases and medical microbiology are available.

Section head: Dr. Yoav Keynan

Nephrology

The Section of Nephrology at the University of Manitoba comprises a large team of 27 academic faculty members and over 700 interdisciplinary research, administrative and clinical personnel dedicated to providing outstanding patient-centred care, research and education in the areas of kidney disease, dialysis and transplantation. The section is fully aligned with the Manitoba Renal Program and Transplant Manitoba, and collectively manages over 2000 advanced stage CKD patients, over 1600 kidney failure patients on dialysis (380 on home dialysis, and over 290 in satellite hemodialysis units dispersed across the province of Manitoba), and over 700 prevalent transplant patients across its three main sites of operation (Health Sciences Centre, St Boniface Hospital, and Seven Oaks Hospital).

The section also runs general nephrology clinics (25 half day clinics per week) and provides on-site nephrology consultation to its three main hospital sites as well as remote telehealth support to all hospitals in the province of Manitoba, Northwestern Ontario and Nunavut. The section and its allied programs are leaders and innovators in areas of CKD and Transplant risk assessment, risk stratification, exercise programming in CKD, multidisciplinary care models, remote care delivery and interventional nephrology.

The section provides a productive and highly collaborative research environment, with internationally recognized expertise in the areas of translational, clinical, epidemiologic, health economic and implementation science in both native and transplant kidney disease. This activity is anchored by two research clusters in renal transplant and systems biology (Health Sciences Centre campus) and at the Chronic Disease Innovation Centre (Seven Oaks Hospital Campus). The 10 core researchers in the Section collectively hold over $8 million in peer reviewed research support and publish 40-50 peer reviewed articles per year, many in premier journals. Current research is broadly (but not exclusively) structured along the following themes: Optimal detection and prevention of CKD (CanSolve-CKD SPOR); optimizing outcomes and quality of life in CKD and in Kidney Failure; optimizing kidney transplant rates and outcomes and optimizing AKI diagnosis and treatment.

Section head: Dr. Joe Bueti

Neurology

The Neurology Residency Program at the University of Manitoba runs over the course of five years and as of July 2020, new residents entering the program will experience in the Competence By Design Curriculum (CBD). The majority of training is completed at Health Sciences Centre (HSC), the largest tertiary care hospital in Manitoba.

During inpatient neurology rotations at HSC, residents will work on a team with other trainees supervised by a stroke neurologist and a general neurologist on-call. The stroke neurologist runs the stroke service which includes the diagnosis and management of hyperacute strokes, in-hospital stroke prevention consultations and management of stroke inpatients on the high-observation unit and neurology ward. The general neurologist runs the general neurology service which includes a five bed inpatient service and a busy general neurology consultation service. Due the large HSC catchment area, residents will be exposed to a wide variety of neurological presentations.

With an average of three residents per year, there are a total of fifteen residents in the program which allows for a collegial and supportive resident environment. There are twenty faculty neurologists who are dedicated to residency education. The small size of the section of neurology fosters close, often one-on-one supervision and mentorship between faculty and residents. Importantly, the section has grown and continues to grow. In 2015, there were ten residents, and six faculty neurologists have been recruited since 2020.

The residency curriculum is reviewed in detail in the ‘Program Curriculum’ section. Particular highlights of the curriculum include a longitudinal outpatient clinic for residents in PGY3 and higher, dedicated outpatient clinic time in a variety of subspecialty and general neurology clinics and six blocks of elective time. Residents enjoy significant flexibility in the scheduling of their rotations, particularly in their senior years. Highlights of the Academic Curriculum include a new modular-based academic half-day curriculum with regular formative short-answer style exams and three formative practical OSCE exams per year.

Finally, our residency program prioritizes residents. Residents are invited to be involved in curriculum development and program quality improvement through positions in the Curriculum Development Committee, Competence Committee and Residency Training Committee. Resident wellness is valued and promoted during the academic half-day curriculum and with a resident retreat supported by the program. Our program teaches residents that a neurologist must balance left with right, textbook reading with clinical experience and professional career with a holistic lifestyle.

Section heads: Dr. Brian Schmidt, Dr. Dan Robert

Proteomics and Systems Biology

The Manitoba Centre for Proteomics and Systems Biology (MCPSB) was established to use high content approaches to study questions of biological and medical relevance. The MCPSB is dedicated to the promotion and practice of systems biology and proteomics in Manitoba, both in academia and industry. The centre also functions as a resource for the research community of Manitoba offering intellectual and technical expertise on a collaborative basis.

The MCPSB resides in a 10,000 square foot laboratory and office facility on the seventh floor of the John Buhler Research Centre on the Bannatyne Campus of the University of Manitoba. The space houses most of the biological activities of the MCPSB. Our approach has been to consolidate expertise in several areas of basic and clinical research at one site to encourage interaction, discussion and collaboration.

Section head: Dr. John Wilkins

Physical Medicine and Rehabilitation

The eight physiatrists in the Section of Physical Medicine and Rehabilitation (PMR) specialize in the area of rehabilitation medicine, dealing with muscles, bones, nerves, function and mobility. Our inpatient rehabilitation units are located at the Rehabilitation Hospital, Health Sciences Centre and the Riverview Health Centre. Outpatient clinics are located at the Rehabilitation Hospital, Health Sciences Centre, Riverview Health Centre and the Pan Am Clinic.

Our faculty members actively participate in undergraduate, postgraduate and continuing medical education. The PMR residency program currently has nine residents.

Section head: Dr. Ryan Skrabek

Respiratory Medicine

Respiratory medicine (respirology) is a subspecialty of internal medicine concerned with the diagnosis and treatment of diseases of the respiratory system such as advanced chronic obstructive pulmonary disease, interstitial lung diseases, pulmonary arterial hypertension, tuberculosis and pulmonary fibrosis. They also provide ongoing care for lung transplant patients and patients with chronic respiratory failure.

Respiratory medicine physicians and their team provide detailed assessments, treatments, and education for the province of Manitoba, as well as northern communities in Canada and parts of Northwestern Ontario.

Adult respirology clinics are located at Winnipeg’s largest hospitals, The Health Sciences Centre and the St. Boniface General Hospital Our respirologists are involved in the evaluation of patients with various sleep disorders including sleep-disordered breathing work at the Sleep Disorder Centre located at the Misericordia Health Centre.

Respiratory medicine physicians also provide coverage at the Riverview Health Centre.

Section head: Dr. Martha Ainslie

Rheumatology

The Section of Rheumatology is based at the Health Sciences Centre in Winnipeg with seven full time faculty members who provide ambulatory care services as well as clinical consultation and inpatient care to patients with all types of musculoskeletal and autoimmune diseases.

We are committed to providing outstanding clinical care for both the most complex patients as well as vulnerable populations; all levels of medical education; and cutting edge research to improve the health, treatments, outcome and quality of life for our patients.

The section is home to an endowed Rheumatology Research Chair. Our researchers are at the forefront of research ranging from basic science and translational research to epidemiology and clinical trials, and reflect the varied interests and activities of our faculty members: the pathogenesis of rheumatoid synovitis and the mechanisms involved in the initiation of synovial inflammation, systemic lupus erythematosus, rheumatic disease in First Nations people, cohort studies to predict and optimize RA outcomes, biomarkers and disease pathogenesis, scleroderma, and disparities in rheumatology care.

A major strength of the section is the strong collaborations we have cultivated with other sections and departments at the University of Manitoba, and with other leading universities, institutions and organizations in Canada and abroad.

Faculty members are actively engaged in undergraduate and postgraduate education. The Rheumatology Training Program is a two-year program undertaken by candidates with training in Internal Medicine. Residents must have completed three or four years of General Internal Medicine training prior to entering the program.

Section head: Dr. Christine Peschken

Programs of study

The Department of Internal Medicine trains physicians across all levels to a high degree of excellence. Our education programs teach students the importance of patient-centred care, readying them to provide tertiary medicine in an effective and efficient way.

Internal medicine awards

The Department of Internal Medicine offers several awards based on academic merit and professional achievement.

B.J. Kaufman CTU Teaching Award

The Barry J. Kaufman CTU Clinician Educator Award was named in November 2005 to recognize a clinician educator amongst the CTU Attendee Group.

The award is granted every two years to one individual who has been on staff for a minimum of three years. The award will be announced at a departmental event.

The award will consist of:

  • A monetary award of $5,000 given to the individual
  • An engraved presentation to the awardee
  • The name of the awardee will be engraved on the plaque in the Department of Internal Medicine
  • The monetary award is regarded as income to the individual and must be included in the individual’s income (non-tithable, taxable).

Criteria for evaluation

Using the numerical scores from Resident Evaluations of attending physicians over the last four year period, the highest numerical score will determine the names of four individuals with the highest score.

  • Clinical decision maker
  • Feedback
  • Communication with Residents and families
  • Teaching
  • Coaching physical examination skills
  • Back-up for house staff
  • Punctuality
  • Attending as a role model

Last time winners eliminated for second round only, but eligible for third round.

The names will be presented to the Award Selection Committee that will recommend the name of the awardee to the Department Head.

    Dale Iwanoczko Award

    Dr. Dale Iwanoczko was a resident in the Internal Medicine Postgraduate Program at the University of Manitoba from 1993 to 1996. He became a Fellow of the Royal College of Physicians and Surgeons in Internal Medicine in 1997, and went on to a further year of training in Infectious Diseases before his untimely death due to lymphoma in 1998.

    Dale Iwanoczko was an exceptional person and physician. He maintained a healthy balance between his personal and professional life. Through his outstanding achievements as an athlete, and his warm relationships with family and friends, he was known for his honesty, humility, commitment to excellence, sportsmanship, humour and caring. He brought the same qualities to his work as a physician, along with an inquiring mind, compassion and dedication to both the art and science of medicine.

    The Dale Iwanoczko Award is a bursary derived from a fund established through the Department of Internal Medicine at the University of Manitoba in honour of Dale’s memory, achievements and his many gifts of mind and spirit to patients, colleagues, friends and family.

    The award consists of fund that may be used for travel to a professional conference or for the purchase of educational material including books or journals. The award will be given on an annual basis to a resident in one of the first three core Internal Medicine training years at the University of Manitoba who best expresses the personal and professional values personified by Dale Iwanoczko.

    The recipient will be designated by a committee consisting of:

    • the Postgraduate Program Director - Core
    • a Chief Resident from the program
    • a third member designated by the Department Head

    The award is presented at the Spring Resident Research Day historically held in May. The names of the award recipients will be recorded on the Dale Iwanoczko Award plaque located in the Residents Rooms at both the Health Sciences Centre and the St. Boniface Hospital.

    Dr. Hector Ma Award

    With a gift of $200,000 in 2015, Dr. Hector T. G. Ma has established an endowment fund at the University of Manitoba. The purpose of the fund is to enhance resident research in the field of Internal Medicine by recognizing students in the Postgraduate Medical Education Program performing research in Internal Medicine.

    Dr. Ma is a graduate of the University of Manitoba (MD/59) and is currently the Director and Senior Consultant Radiologist in the Scanning Department at St. Teresa’s Hospital in Hong Kong. In addition to Dr. Ma’s gift, the Department of Internal Medicine has agreed to annually provide matching funds (to a maximum of $8,000 per year) to offer the award.

    Eligibility Criteria

    • Enrolled full-time in the Postgraduate Medical Education Program in the Max Rady College of Medicine and is in good standing;
    • Performing a supervised research project as a resident in the Department of Internal Medicine;
    • Demonstrated outstanding interest or commitment to research in Internal Medicine.

    Funding and Grant Duration

    • The award is in the amount of up to $16,000.00; the available annual income from the fund, plus the Department of Internal Medicine’s matching contribution.
    • Funds will be deposited into a UofM FOAP for the resident to use to further the research proposal submitted.
    • The funding term is two years - with one additional year to expend any remaining funds. Funds remaining after the three year period will be returned to the Dr. Hector Ma Award fund.

    Criteria for Prioritization

    Proposals will be judged based on scientific merit and priority will be given based on:

    • Novelty (new initiative with high potential to result in relevant innovation)
    • Collaboration (projects establishing partnerships within and beyond the Department of Internal Medicine and the University of Manitoba)
    • Feasibility (high likelihood of success based on track record/training of applicant, on collaborator(s), environment, budgeted to complete project within two years)
    • Alignment with the Strategic Research Plan of the Department of Internal Medicine

    Deadline for Submission

    For 2020/2021: Noon on December 31, 2020.

    Application and Submission Guidelines

    Proposal

    The application form at this link must be used to be in compliance with the rules below.

    Length: The body of the research proposal must not exceed three pages (11 pt font Arial or 12 pt font Times New Roman) including tables and figures.

    Structure: All proposals should have the following information, in order:

    • Title of the research project
    • Contact information and roles of applicants (principal investigator=applicant, co-investigator(s), collaborator(s))
    • Background / Rationale
    • Hypothesis
    • Objectives
    • Specific Aim(s) (for each specific aim: materials/methods, [statistical] analysis incl. sample size calculation, if applicable, expected outcomes and contingency plan)
    • Timeline
    • Significance
    • Plan for dissemination and knowledge translation/transfer
    • References (must not exceed two additional pages)
    • Budget (must not exceed one additional page)
    • Information on how the applicant meets the eligibility criteria

    Curriculum Vitae

    The applicant must submit an updated CV (preferably Common CV).

    Letters of Support

    Letters of support by collaborators must be included (if applicable).

    Submission

    The proposal, CVs and letters of support must be submitted via e-mail as an attachment merged into a single document that is addressed to the attention of:

    Department of Internal Medicine
    Health Sciences Centre
    GC430-820 Sherbrook Street
    Winnipeg MB R3A 1R9

    Proposals that do not follow the above structure and/or exceed the maximal length allowed and/or are received after the deadline set for submission will be rejected without review.

    Review Committee and Process

    For each competition, the Research and Faculty Development Committee will review each application, scoring them using a system similar to the CIHR 0.0-4.9 grade scale. The Review Committee will use the following criteria to evaluate proposals:

    Research Approach

    • Clarity of the research question
    • Clarity of rationale for the research approach and methodology
    • Appropriateness of the research design
    • Appropriateness of the research methods
    • Feasibility of the research approach (including recruitment of subjects, project timeline, preliminary data where appropriate, etc.)
    • Anticipation of difficulties that may be encountered in the research plans for management

    Originality of the Proposal

    • Potential for the creation of new knowledge
    • Originality of the proposed research, in terms of the hypotheses/research questions addressed, novel technology/methodology, and/or novel applications of current technology/methodology.

    Applicant(s)

    • Qualifications of the applicant(s), including training, experience and independence (relative to career stage)
    • Experience of the applicant(s) in the proposed area of research and with the proposed methodology
    • Expertise of applicant(s)
    • Potential to successfully and appropriately disseminate research findings
    • Appropriateness of the team of applicants (if more than one applicant) to carry out the proposed research, in terms of complementary of expertise and synergistic potential

    Research Environment

    • Availability and accessibility of personnel, facilities and infrastructure required to conduct research
    • Suitability of the environment to conduct the proposed research
    • Suitability of the environment (milieu, projects, and mentors) for the training of personnel (if applicable)

    Impact of Research

    • Research proposal addresses a significant need or gap in biomedicine/health care
    • Potential for a significant contribution to the improvement of understanding of biomedical mechanism(s) relevant to people’s health and/or to the development of more effective health care
    • Appropriateness and adequacy of the proposed plan for knowledge dissemination and exchange

    Duties of the Awardee

    • Any project-related manuscript(s) or presentations must acknowledge the Department of Internal Dr. Hector Ma Award as a source of support.
    • Awardees must send the Department of Internal Medicine a copy of any abstract(s), publication(s), and/or peer-reviewed grant application(s) that are, fully or in part, the results of this funding.
    • The Awardee will be asked to present at a Grand Rounds within the academic year of the award.

    Screening tool

    • Is enrolled full-time in the Postgraduate Medical Education program in the Max Rady College of Medicine and is in good standing;
    • Is performing a supervised research project as a resident in the Department of Internal Medicine;

    Submission guidelines

    Length: The body of the research proposal must not exceed three pages (11 pt font Arial or 12 pt font Times New Roman) including tables and figures.

    1. Title of the research project
    2. Contact information and roles of applicants (principal investigator:applicant, co-investigator(s), collaborator(s))
    3. Background / Rationale
    4. Hypothesis
    5. Objectives
    6. Specific Aim(s) (for each specific aim: materials/methods, [statistical] analysis incl. sample size calculation, if applicable, expected outcomes, and contingency plan)
    7. Timeline
    8. Significance
    9. Plan for dissemination and knowledge translation/transfer
    10. References (must not exceed one additional page)
    11. Budget (must not exceed one additional page)
    12. Information on how the applicant meets the eligibility criteria
    13. The principal investigator and each co-investigator must submit an updated CV (preferably Common CV).
    14. Letters of support by collaborators must be included (if applicable).
    15. Submitted via e-mail as an attachment merged into a single document that is addressed to the attention of Ingrid Reuter

    Dr. J.P. Maclean Memorial Lectureship

    The John P. Maclean Lectureship was established to perpetuate the memory of Dr. Maclean’s personal qualities and his professional contribution to Medicine. Dr. Maclean established the Section of Endocrinology and the discipline of Nuclear Medicine. He was instrumental in developing an awareness of ethical issues in clinical medicine and was the first Chairman of the University of Manitoba Ethics Committee.

    Born in Alexandria, Scotland in 1926, Dr. Maclean emigrated to Canada with his family in 1932. He attended Ridley College in St. Catharines, Ontario and graduated in 1950 from the Faculty of Medicine at the University of Manitoba. After post-graduate work at the Sloan Kettering Hospital in New York, he returned to Winnipeg and St. Boniface Hospital in 1955 as a member of the Department of Medicine and established the Section of Endocrinology and the discipline of Nuclear Medicine. He was a dedicated teacher and confidant of residents and colleagues. He served the University and Hospital tirelessly and with distinction. Dr. Maclean was instrumental in developing an awareness of ethical issues in clinical medicine and was the first Chairman of the University Medical Ethics Committee. The John P. Maclean Lectureship was established to perpetuate the memory of Dr. Maclean’s personal qualities and his professional contribution to Medicine. Dr. Maclean was admired and respected by his patients for his sensitivity and judgement. In life he was a role model for medical students and resident physicians. His colleagues in the Department of Internal Medicine and the University community will remember his abiding sense of compassion and optimism.

    Emy Ozamoto Resident Research Award for Quality Improvement

    Mrs. Emy Ozamoto was the first Clinical Education Coordinator for the Department of Internal Medicine – a position she developed and held for nearly 25 years. In 2014, the Ozamoto family, as well as Emy’s friends and colleagues from Internal Medicine established an endowment fund at the University of Manitoba in recognition of her education to the Internal Medicine Residency Program. The purpose of the award is to encourage resident research in quality improvement initiatives, which will lead to enhanced patient outcomes.

    Criteria for evaluation

    Each year, beginning in 2015-2016, to a student who:

    • was enrolled full-time, in good standing, in the Postgraduate Medical Education Program in the Department of Internal Medicine in the College of Medicine, in the year in which the prize was tenable;
    • has presented the best quality improvement project focused on improving patient outcomes and service delivery at the Annual Department Resident Research Day.

    Research projects (podium or poster presentations) will be evaluated using the following criteria:

    • Abstract – 20 points
    • Presentation – 50 points
    • Knowledge base and preparation – 20 points
    • Independence – 10 points

    The award

    The available annual income from the fund will be used to offer one prize, however if warranted, and at the discretion of the selection committee, the award may be divided equally between two worthy recipients.

    In the event that no residents have submitted quality improvement projects in any given year, the award will not be offered and the annual income for that year will remain in the fund.

    The award recipient(s) will be announced at the annual Resident Research Dinner and the name(s) of the recipients will be engraved on the Emy Ozamoto Award plaque located in the Department of Internal Medicine on GC4 at the Health Sciences Centre.

    The Dean of the College of Medicine (or designate) will ask the Resident Research Day panel of judges to act as the selection committee for this award.

    The Board of Governors of the University of Manitoba has the right to modify the terms of this award if, because of changed conditions, it becomes necessary to do so. Such modification shall conform as closely as possible to the expressed intention of the donor in establishing the award.

    Liam J. Murphy Young Investigator Award

    The Liam J. Murphy Young Investigator Award was established in November 2006. The award is given to a young investigator every two years to a faculty member who has been on staff for less than six years and who shows evidence of developing a strong research program.

    The award is granted every two years to one individual and announced at a departmental event.

    The Young Investigator Grant Application form (PDF) must be filled out.

    Criteria for Evaluation

    Multiple peer-reviewed publications
    National or international recognition (invitation to present and speak)
    Success in obtaining local or national funding

    Selection

    As this is a research award, Section Heads nominate individuals and present the candidates to Executive Committee who then vote via secret ballot.

    The Award

    The award will consist of:

    • A monetary award of $20,000 for research support.
    • An engraved presentation to the awardee.
    • The name of the awardee will be engraved on the plaque in the Department of Internal Medicine.
    • The award is made available to an individual who holds an academic appointment at a university, hospital or similar institution to enable the individual to carry on research or similar work.
    • A letter will be sent from the department to the awardee, advising to contact their respective Physician Services Manager who will setup a FOAP the University. Once set up, the FOAP will have $20,000 deposited from UMG overhead.
    • The amount is to be paid directly to the university or hospital. It cannot be used to incur a personal benefit to the individual.

    Long-term Achievement Pin Award

    The Long-term Achievement Pin Award was created in November 2017 created to recognize the long-term achievements of an outstanding senior faculty member.

    The award is granted every one to three years.

    Criteria for Evaluation

    Candidates for this award must:

    • Hold a GFT or UMFA appointment in the Department
    • Have a proven, exceptional track record as an outstanding academic role model in at least three of the following domains:
      • clinical service
      • research
      • teaching/education
      • mentoring
      • administration.

    While the inaugural awardee, Dr. Ken Van Ameyde was selected in November 2017 by Dr. Eberhard Renner, going forward each awardee’s task will be to select their own successor within a minimum of one and a maximum of three years, and to give grand rounds on a topic of their choice illustrating, in particular to junior faculty and residents, what the awardee thinks has been pivotal for them to become an academic role model.

    Morley Lertzman Subspecialty Teaching Award

    The Morley Lertzman Subspecialty Clinician Educator award was named in November 2005 to recognize a Clinician Educator among the subspecialty attending staff.

    The award is granted every two years. The award will be announced at a departmental event.

    The award will consist of:

    • A monetary award of $5,000 given to the individual
    • An engraved presentation to the awardee
    • The name of the awardee will be engraved on the plaque in the Department of Internal Medicine
    • The monetary award is regarded as income to the individual and must be included in the individual’s income (non-tithable, taxable).

    Criteria for Evaluation

    Using the numerical scores from Resident Evaluations of attending physicians over the last four year period, the highest numerical score will determine the names of four individuals with the highest score.

    • Clinical decision maker
    • Feedback
    • Communication with Residents and families
    • Teaching
    • Coaching physical examination skills
    • Back-up for house staff
    • Punctuality
    • Attending as a role model

    Last time winners eliminated for second round only, but eligible for third round.

    The names will be presented to the Award Selection Committee that will recommend the name of the awardee to the Department Head.

    New Investigator Grant Competition

    Scope and purpose

    The New Investigator Grant Competition is sponsored by the Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, at the University of Manitoba. The competition will be held on an annual basis to support research activities of junior faculty members (less than five years since the initial appointment) within the Department of Internal Medicine. The purpose of the grant is to allow a new investigator to generate preliminary results that will enable him/her to subsequently apply for an extramural grant, i.e. the Department’s New Investigator grant is meant to serve as seed money for starting a research career.

    Principles

    1. The grants serve as start-up funds (seed money) for new investigators at the beginning of their research careers (less than five years since initial appointment as junior faculty).
    2. Applicants are expected to apply to an extramural peer reviewed granting agency within two years of receiving the Young Investigator award.
    3. Priority will be given to applicants who have secured matching funds from alternative funding sources (i.e. Health Sciences Centre Foundation, St. Boniface Research Foundation, CancerCare Manitoba Foundation, Heart and Stroke Foundation of Manitoba, others).

    Eligibility criteria

    This competition is open to individuals with a primary academic appointment in the Department of Internal Medicine at the University of Manitoba. The applicant will ideally hold a minimum of 0.5 EFT in research to apply for this competition. This competition is open to applicants with less than five years since their appointment as junior faculty (Assistant Professor level) to the Department of Internal Medicine. Faculty members who hold Tri-council operating funds or received the New Investigator Grant (former Young Investigator Grant Competition) in the past are NOT eligible for subsequent competitions. Applications may cover clinical, translational or basic research.

    Funding and grant duration

    1. The award is in the amount of $25,000.00 annually for two years.
    2. The award can be used to cover operating costs, costs of minor equipment and/or salary support for research staff, but cannot be used as salary support for the applying faculty member.
    3. The number of awards given out each year may vary subject to availability of funds.

    Criteria for prioritization

    Proposals will be judged based on scientific merit and priority will be given based on:

    1. Novelty (new initiative with high potential to result in relevant innovation)
    2. Collaboration (projects establishing partnerships within and beyond the Department of Internal Medicine and the University of Manitoba)
    3. Feasibility (high likelihood of success based on track record/training of applicant, on collaborator(s), and environment)
    4. Alignment with the Strategic Research Plan of the Department of Internal Medicine

    Deadline for submission

    January 31 with decisions expected no later than April 1 of each year.

    Proposal

    Length: The body of the research proposal must not exceed four pages (11 pt font Arial or 12 pt font Times New Roman) including tables and figures.

    Structure: All proposals should have the following information, in order:

    1. Title of the research project
    2. Contact information and roles of applicants (principal investigator=applicant, co-investigator(s), collaborator(s))
    3. Background / Rationale
    4. Hypothesis
    5. Objectives
    6. Specific Aim(s) (for each specific aim: materials/methods, [statistical] analysis incl. sample size calculation, if applicable, expected outcomes, and contingency plan)
    7. Timeline
    8. Significance
    9. Plan for dissemination and knowledge translation/transfer
    10. References (must not exceed two additional pages)
    11. Budget (must not exceed one additional page)

    Curriculum Vitae

    The principal investigator and each co-investigator must submit an updated CV (preferably Common CV). If the co-investigator is part of the Department of Internal Medicine, a CV is not required

    Letters of Support

    Letters of support by collaborators must be included (if applicable).

    Submission

    The proposal, CV’s, and letters of support must be submitted via email as an attachment merged into a single document that is addressed to the attention of:

    Tonya Derkson
    Department of Internal Medicine
    Health Sciences Centre
    GC430-820 Sherbrook Street
    Winnipeg MB R3A 1R9

    Proposals that do not follow the above structure and/or exceed the maximal length allowed and/or are received after the deadline set for submission will be rejected without review.

    Review committee and process

    For each competition, the Head of the Department of Medicine or delegate may assemble a Review Committee composed of three to five established researchers from different Sections within the Department with experience in clinical, translational and/or lab-based research or ask the Research and Faculty Development Committee to review the applications.

    The Head of the Department of Internal Medicine or delegate will chair the Review Committee and will not exercise a vote except if there is a tie.

    In case of a conflict of interest, the committee member with the conflict will have to exclude him/herself from reviewing an application and from participating in the discussion of a proposal. It is up to the committee chair to decide whether an external review of a proposal is required. The Review Committee will score the applications using the CIHR scoring system, and use the following criteria to evaluate proposals:

    Research approach

    • Clarity of the research question
    • Clarity of rationale for the research approach and methodology
    • Appropriateness of the research design
    • Appropriateness of the research methods
    • Feasibility of the research approach (including recruitment of subjects, project timeline, preliminary data where appropriate, etc.)
    • Anticipation of difficulties that may be encountered in the research plans for management

    Originality of the proposal

    • Potential for the creation of new knowledge
    • Originality of the proposed research, in terms of the hypotheses/research questions addressed, novel technology/methodology, and/or novel applications of current technology/methodology.

    Applicant(s)

    • Qualifications of the applicant(s), including training, experience and independence (relative to career stage)
    • Experience of the applicant(s) in the proposed area of research and with the proposed methodology.
    • Expertise of applicant(s)
    • Potential to successfully and appropriately disseminate research findings
    • Appropriateness of the team of applicants (if more than one applicant) to carry out the proposed research, in terms of complementary of expertise and synergistic potential.

    Research environment

    • Availability and accessibility of personnel, facilities and infrastructure required to conduct research
    • Suitability of the environment to conduct the proposed research
    • Suitability of the environment (milieu, projects, and mentors) for the training of personnel (if applicable)

    Impact of research

    • Research proposal addresses a significant need or gap in biomedicine/health care.
    • Potential for a significant contribution to the improvement of understanding of biomedical mechanism(s) relevant to people’s health and/or to the development of more effective health care.
    • Appropriateness and adequacy of the proposed plan for knowledge dissemination and exchange.

    Duties of the awardee

    1. During the funding period, grant recipients must submit an annual progress report by May 31 of the following year (one page report highlighting progress to date and future plans). Funding for the second year is conditional on a satisfactory progress report.
    2. Any project-related manuscript(s) or presentations must acknowledge the Department of Internal Medicine New Investigator Grant as a source of support.
    3. Awardees must send the Department of Internal Medicine a copy of any abstract(s), publication(s), and/or peer-reviewed grant application(s) that are, fully or in part, the results of this funding.

    Research

    We are leaders in key areas of biomedical research and innovation at a national and international level. As we continue to research tertiary patient care, our aim is to gain international recognition in key areas.

    • $15M

      awarded in grant funding in 2020

    • $38M

      department endowment market values

    • 1695

      citations in 2020

    • 555

      departmental publications in 2020

    Research groups

    The Department of Internal Medicine has a number of research groups. A research group is an association of University scholars who share research interests and who engage in collaborative or closely related research activities. The purpose of a research group is to promote and facilitate communication and collaboration among its members and to establish the legitimacy of the group both inside and outside the University.

    Critical Care and Medicine Database

    The Critical Care and Medicine Database collects prospective data for Critical Care and Medicine research, operations and quality control. This powerful tool links two data sets: a clinical ICU database containing detailed information about every adult ICU admission and the provincial administrative database held at the Manitoba Centre for Health Policy, which contains comprehensive, linked information about all provincial residents, including vital status, all hospitalizations, outpatient visits, prescription pharmaceuticals, home care, use of chronic care facilities and over 100 other datasets.

    Diabetes Research Group

    The objective of the Diabetes Research Group is to provide both basic and clinical research in diabetes. The research group has a core of successful investigators who have received recognition nationally and internationally through competitive research funding and clinical contracts.

    IBD Clinical and Research Centre

    Established in 1994, the IBD Clinical and Research Centre has received international attention and recognition. It has the largest IBD database in North America. In collaboration with researchers at John Hopkins University, this research group is studying the prevalence of NOD2 gene abnormalities in Manitobans with Crohn's Disease.

    Liver Diseases Research Group

    The principal goal of the liver diseases research group is to enhance the understanding and thereby develop more effective therapy for inflammatory disorders of the hepatobiliary system. Much of the research being performed employs recombinant DNA physiology, animal models and patients with viral hepatitis. The results are relevant to other common liver disorders including alcoholic hepatitis, fatty liver, drug induced hepatitis, primary bilary cirrhosis and primary sclerosing cholangitis.

    Manitoba Centre for Proteomics and Systems Biology

    The objective of the Manitoba Centre for Proteomics and Systems Biology (MCPSB) is to provide core expertise and services in several areas of relevance to the biological and medical research community in Manitoba and Canada. These areas include but are not limited to bioinformatics, proteomics, protein separation, mass spectrometry, monoclonal antibody production and high content image analysis.

    Endowed research chairs

    The Department of Internal Medicine at the University of Manitoba is home to nine endowed research chairs created through contributions from individuals, foundations, corporation and/or faculty members. A chair is established with a sizeable gift to an academic area designated by the donor; the gift is invested in an interest-bearing fund for which the principal remains intact and the interest provides a perpetual source of annual income. This income provides valuable financial support to our chair holders.

    Bingham Chair in Gastroenterology

    The Bingham Chair in Gastroenterology is named for Dr. John Bingham. The Bingham Chair in Gastroenterology, established in 2008, was created to advance research in the field of gastrointestinal disorders and Inflammatory Bowel Disease, named for Dr. John Bingham.

    Dr. Bingham contributed $1,000,000 towards this endowment. Dr. Bingham is a graduate of the University of Manitoba, Faculty of Medicine, Class of 1940. From 1940 to 1945, Dr. Bingham served as a naval surgeon, first in a Canadian destroyer attached to the British Navy in the Battle of the Atlantic and later stationed in Halifax, Nova Scotia.

    The generous contributions of the donors who made this chair possible include:

    • Dr. John R. Bingham
    • Dr. Alfred E. Deacon Medical Research Foundation
    • Axcan Pharma Inc.
    • Cathy and Bob Tallman
    • Leonard and Susan Asper
    • Marty and Michelle Weinberg and Family
    • Mr. Gerry Gray
    • Mr. James R. Morden
    • Mr. Thomas G. Frohlinger and Ms. Heather R. Pullman
    • Mr. Ulysses S. Wagner (estate)
    • Ms. Gail S. Asper and Dr. Michael J. Peterson
    • Richard and Sheree Walder Morantz and Family
    • The Shenkarow Family and the Department of Internal Medicine Physician Faculty

    The role is currently held by Dr. Charles Bernstein.

    Chair in Rheumatology

    The Chair in Rheumatology is named for the Section of Rheumatology. The Rheumatology Research Chair, established in 2003, was created to promote excellence in research, teaching and the care of those suffering from arthritis and other rheumatic diseases. Dedicated to the goal of eliminating the burden of rheumatic diseases for all. The role is currently held by Dr. Hani El-Gabalawy

    Dr. Lyonel G. Israels Chair in Hematology

    The Dr. Lyonel G. Israels Chair in Hematology was created to provide leadership, scholarship and mentorship in the areas of benign and malignant hematology and immunology.

    The role is currently held by Dr. Ryan Zarychanski.

      Evelyn Wyrzykowski Research Chair in Cardiology

      The Evelyn Wyrzykowski Research Chair in Cardiology was created to advance research in the field of cardiac disease. It is dedicated to improving health care for patients with cardiovascular disorders.

      The Department of Internal Medicine gratefully recognizes the generous contributions of the donors who made this chair possible:

      • Mr. Conrad Wyrzykowski
      • St. Boniface Hospital Foundation
      • The Department of Internal Medicine Physician Faculty

      The role is currently vacant.

      Flynn Family Chair in Renal Transplantation

      The Flynn Family Chair in Renal Transplant was created to advance research in the field of renal transplantation. It is dedicated to improving access and quality of outcomes associated with renal transplantation. The Department of Internal Medicine gratefully recognizes the generous contribution of the donors who made this chair possible:

      • Doug and Allyson Flynn
      • The Department of Internal Medicine Physician Faculty
      • Inge Gaspard
      • Flynn Canada Ltd.
      • Renal Transplant Research Fund
      • Astellas Pharma Canada
      • Hoffmann-La Roche Limited
      • Manitoba Branch of the Kidney Foundation of Canada
      • Dr. Alfred E. Deacon Medical Research Foundation

      The role is currently held by Dr. Peter Nickerson.

      H.E. Sellers Research Chair in Internal Medicine

      The H.E. Sellers Research Chair in Internal Medicine, established in 2001, was made possible by a generous donation from the Sellers Foundation. It was setup to provide leadership and vision for the creation of new areas of strength in clinical and translational research. The chair is named after Henry Eugene Sellers (1886-1970). Mr. Sellers established the Sellers Foundation to "further medical research, religious education and other charitable activities."

      The role is currently held by Dr. Kelly MacDonald.

      Morberg Family Chair in Hepatology at the Health Sciences Centre

      The Morberg Family Chair in Hepatology at the Health Sciences Centre was created to advance research in the field of liver diseases.

      The Morberg Family Chair in Hepatology at the Health Sciences Centre was established in 2010 to advance research in the field of liver diseases and is dedicated to improving health care for patients with hepatobiliary disorders. Funding enhances the competitiveness of the faculty to recruit top researchers to improve the quality of life for liver patients not only in Manitoba but around the world.

      The Department of Internal Medicine gratefully recognizes the generous contribution of the donors who made this chair possible:

      The role is currently held by Dr. Gerald Minuk.

      Quality Improvement and Health Services Design Research Chair

      The Quality Improvement and Heath Services Design Research Chair was created to advance innovation in the function and design of medical services, aimed at improving the effectiveness and safety of patient care, and dedicated to the development of leadership and management skills for physicians.

      The Department of Internal Medicine gratefully recognizes the generous contribution of the donors who made this chair possible:

      • Department of Internal Medicine 2001-2006 Physician Faculty
      • Health Sciences Centre
      • WRHA Medicine Program

      The role is currently vacant.

      Waugh Family Chair in Multiple Sclerosis

      The Waugh Family Chair in Multiple Sclerosis, established in 2014, was created to advance research in the field of multiple sclerosis (MS) and is dedicated to improving health care for patients living with MS.

      MS is a chronic, often disabling disease of the central nervous system compromising the brain, spinal cord and optic nerve. It is estimated to affect more than 3,400 Manitobans and 100,000 Canadians.

      Funding assists Manitoba researchers, partnered with the MS Society to make new discoveries that enhance understanding of the causes of MS and have a positive impact on its treatment.

      The Department of Internal Medicine gratefully recognizes the generous contribution of the donors who made this chair possible:

      • Waugh Family Foundation
      • College of Medicine, Faculty of Health Sciences, University of Manitoba
      • Research Manitoba
      • Dr. Alfred E. Deacon Medical Research Foundation Inc.
      • The Department of Internal Medicine Physician Faculty

      The role is currently held by Dr. Ruth Ann Marrie.

      Professorships

      Friesen Professorship in Endocrinology

      This opportunity was created to advance the university’s academic goals and objectives through leadership, scholarship and mentorship work of an appointed member of the department in the areas of endocrine and metabolic diseases. Funding is derived from a $1.5 million endowment and will span over a five-year term to support the appointee in their initiatives. This professorship was created in honour of Dr. Henry Friesen’s many achievements, which includes the discovery of the hormone, prolactin. Dr. Friesen was born in Morden, Manitoba and graduated from the University of Manitoba’s Medical School in 1958. He trained as an endocrinologist at the New England Center Hospital (Boston), before returning to Winnipeg as Head of the Department of Physiology. Dr. Friesen held many important leadership roles with various research foundations, initiatives and medical councils.

      The professorship is currently held by Dr. Jennifer Yamamoto.

      Moorhouse Professorship in Diabetes Research

      This professorship has been established to support a clinician-scientist in the Section of Endocrinology for related research, with a focus on finding a cure and improving the health care of those suffering from diabetes and related diseases. A portion of the award may be used by the awardee to support a graduate student in endocrinology who is conducting diabetes research. The three-year endowment is supported by the John A. Moorhouse Fellowship, established by the Diabetes Foundation of Manitoba in 2008. Dr. Moorhouse’s legacy lives on through the newly created Professorship; he was a University of Manitoba Medical School alumni (1950), faculty member and former Head of the Section of Endocrinology, Department of Internal Medicine. He was the creator of the Endocrine and Metabolism Laboratory, serving as the Director for 15 years and was a pioneer in the field of diabetes research in Manitoba.

      Undergraduate Research Awards

      Student working with a test-tube.

      Undergraduate Research Awards

      Each year, the University of Manitoba provides a multitude of unique learning opportunities through the undergraduate research awards. This program allows undergraduate students to interact with the best minds and research leaders in their fields. This experience opens them up to new possibilities for a research career in either government, academic or industry sectors.

      Resident research day

      Internal Medicine Resident Research Day

      This virtual event will be held over Zoom on Tuesday, November 16, 2021. Please follow the tabs for full details.

      Program at a glance

      8:00 a.m.
      Grand Rounds, “Research During a Pandemic: Building the Plane While Flying It”
      Guest speaker Dr. Srinivas Murthy, MD.
      Presented via Zoom

      9:10 a.m.
      Introductory remarks
      Dr. Navdeep Tangri, Chair, Department of Internal Medicine Resident Research Day

      9:15 a.m. to 4:05 p.m.
      Podium presentations
      Residents will be in Zoom sessions with podium judges. Here judges will view 10-minute pre-recorded PowerPoint presentations followed by Q&A sessions.

      9:15 a.m. to 10:30 a.m.
      Poster presentations
      Residents will be in Zoom sessions with poster judges. Judges have already viewed the three-minute pre-recorded PowerPoint presentations. These sessions are Q&A sessions.

      12:30 p.m.
      Best published paper derived from November 2019 Residents' Research Day
      Dr. Christie Rampersad, PGY-5 Nephrology Resident
      Presented via Zoom

      1:00 p.m. to 1:30 p.m.
      Break

      Recorded podium presentations

      9:10 a.m.

      Introductory remarks
      Dr. Navdeep Tangri
      Chair, Department of Internal Medicine Resident Research Day


      9:15 a.m. – 10:15 a.m.

      GROUP 1 - presentation (mp4)

      Original Investigation
      Clinical presentation and outcomes of patients presenting with Takotsubo Cardiomyopathy: iFAST
      Presented by: Dr. Anas Alzahrani, PGY2 - Cardiology
      Supervisor: Dr. Shuangbo Liu

      Original Investigation
      Medical cannabis use by rheumatology patients attending a tertiary outpatient clinic: a study of 1000 patients in Canada
      Presented by: Dr. Shane Cameron, PGY3 - Internal Medicine
      Supervisor: Dr. Christine Peschken

      Original Investigation
      Incident and prevalent patients have high pain and fatigue despite differences in disease activity: Data from the Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus (CANIOS) national registry
      Presented by: Dr. Kaien GU, PGY3 - Internal Medicine
      Supervisor: Dr. Christine Peschken

      Original Investigation
      Mass-media and targeted education interventions to minimize delay to hospital in patients with chest pain: A systematic review
      Presented by: Dr. Kirsten Marshall, PGY6 - Cardiology
      Supervisor: Dr. Shuangbo Liu


      10:20 a.m. – 11:20 a.m.

      GROUP 2 - presentation (mp4)

      Original Investigation
      Rifampin combination therapy for staphylococcal prosthetic joint infections: A systematic review and meta-analysis
      Presented by: Dr. Jennifer Ziegler, PGY6 – Critical Care
      Supervisor: Dr. Ahmed Abou-Setta

      Original Investigation
      Risks of melanoma and non-melanoma skin cancers pre- and post-IBD diagnosis
      Presented by: Dr. Mariam Narous, PGY2 - Internal Medicine
      Supervisor: Dr. Charles Bernstein

      Original Investigation
      Prevalence of under-recognized atrial fibrillation in patients with ventricular-paced rhythm
      Presented by: Dr. Liane Arcinas, PGY6- Cardiology
      Supervisor: Dr. Nasir Shaikh

      Original Investigation
      Characteristics, treatment patterns and outcomes of long-term survivors with her2-positive metastatic breast cancer in Manitoba
      Presented by: Dr. Erin McAndrew, PGY2 – Internal Medicine
      Supervisor: Dr. Christina Kim


      11:25 a.m. – 12:25 p.m. 

      GROUP 3 - presentation (mp4)

      Original Investigation
      Effectiveness and financial impact of a provincial policy eliminating routine use of creatine kinase testing for work-up of suspected acute coronary syndrome in the emergency department
      Presented by: Dr. Tony Mao, PGY2 - Internal Medicine
      Supervisor: Dr. Evan Wiens

      Original Investigation
      High output heart failure, a forgotten phenotype: evaluating the incidence, plausible etiologies and outcomes
      Presented by: Dr. Hilary Bews, PGY6 -Cardiology
      Supervisor: Dr. Ashish Shah

      Original Investigation
      Real-world efficacy and safety of dual antiplatelet therapy with ticagrelor as compared to clopidogrel
      Presented by: Dr. Evan Wiens, PGY5 - Cardiology
      Supervisor: Dr. Ashish Shah

      Original Investigation
      Molecular assessment of biopsies from patients with ulcerative colitis reveals heterogeneity in clincal disease activity
      Presented by: Dr. Jeffery Venner, PGY3 – Internal Medicine
      Supervisor: Dr. Brendan Halloran


      12:30 p.m. - 1:00 p.m. 

      Best published paper derived from November 2019 Resident Research Day
      Association of physical activity and poor health outcomes in patients with advance CKD
      Christie Rampersad, Ranveer Brar, Kelsey Connelly, Paul Komenda, Claudio Rigatto, Bhanu Prasad, Clara Bohm and Navdeep Tangri
      AJKD 78(3): 391-398. Sept 2021
      Published online February 10, 2021


      1:30 p.m. – 2:45 p.m.

      GROUP 4 - presentation (mp4)

      Original Investigation
      Feasibility of a family liaison volunteer initiative to support critically ill intensive care unit patients and their families during COVID-19 visitor restrictions
      Presented by: Dr. Megan Sorokopud-Jones, PGY1 – Internal Medicine
      Supervisor: Dr. Kendiss Olafson

      Original Investigation
      Time trends and predictors for surgical excision of large colorectal polyps in Manitoba
      Presented by: Dr. Carmen Tse, PGY2 - Internal Medicine
      Supervisor: Dr. Harminder Singh

      Original Investigation
      Quality assessment of provincial screening program for Lynch Syndrome in Manitoba
      Presented by: Dr. Remington Winter, PGY3 – Internal Medicine
      Supervisor: Dr. Harminder Singh

      Original Investigation
      Impact of botulinum toxin injection on pain and caregiver burden in personal care home residents with hypertonia, a retrospective cohort analysis
      Presented by: Dr. Nicholas Miller, PGY4 – PM&R
      Supervisor: Dr. Karen Ethans

      Original Investigation
      Prevalence of obesity and body mass index in Canada among a rural-urban continuum: a cross-sectional study – the Canadian longitudinal study on aging
      Presented by: Dr. Samuel Quan, PGY5 – Geriatric Medicine
      Supervisor: Dr. Phil St. John


      2:50 p.m. - 4:05 p.m.

      GROUP 5 - presentation (mp4)

      Original Investigation
      Surgical versus chemical androgen deprivation therapy in prostate cancer patients in Manitoba
      Presented by: Dr. Unice Chang, PGY3 – Internal Medicine
      Supervisor: Dr. David Dawe

      Original Investigation
      Impact of age, polypharmacy, and comorbitiy on patient reported outcome trajectory in patients treated for late-stage cancer
      Presented by: Dr. Hongru Ren, PGY2 - Internal Medicine
      Supervisor: Dr. David Dawe

      Original Investigation
      The negative impact of t-cell mediated rejection on renal allograft survival in the modern era
      Presented by: Dr. Christie Rampersad, PGY5 - Nephrology
      Supervisor: Dr. Chris Wiebe

      Original Investigation
      Loop diuretic resistance prediction model
      Presented by: Dr. Joey Mercier, PGY3 - Internal Medicine
      Supervisor: Dr. Navdeep Tangri

      Original Investigation
      Patient navigators for chronic kidney disease and kidney failure: A systematic review
      Presented by: Dr. Ali Taha, PGY3 - Internal Medicine
      Supervisor: Dr. Jay Hingwala

      Recorded poster presentations

      Note: Time indicates resident Zoom sessions with judges only.

      9:15 a.m. – 9:30 a.m.

      GROUP 1

      Original investigation - presentation (.mp4)
      High resolution data modifies intensive care unit dialysis outcome predictions as compared with low resolution administrative data set
      Presented by: Dr. Jennifer Zeigler, PGY6 -Critical Care
      Supervisor: Dr. Barret Rush

      Research proposal - presentation (.mp4)
      The prognostic value of non-invasive ventricular reserve measurements in patients with pulmonary arterial hypertension
      Presented by: Dr. Lauren Bath, PGY2 - Internal Medicine
      Supervisor: Dr. David Christiansen

      Research proposal - presentation (.mp4)
      Incidence and prevelance of hepatocellular carcinoma in Manitoba follow up study cohort
      Presented by: Dr. Pedram Hassan-Tash, PGY2 – Internal Medicine
      Supervisor: Dr. Julia Uhanova

      Research proposal - presentation (.mp4)
      Improving referral rates to pulmonary rehabilitation for patients with COPD exacerbation
      Presented by: Dr. Japandeep Sethi, PGY3 - Internal Medicine
      Supervisor: Dr. Rachel Fainstein


      9:30 a.m. – 9:45 a.m.

      GROUP 2

      Original investigation - presentation (.mp4)
      Patient education using an internet intervention teaching movement patterns in non-specific low back pain: A pilot study
      Presented by: Dr. Ans Sabzwari, PGY5 – PM&R
      Supervisor: Dr. Ryan Skrabek

      Research proposal - presentation (.mp4)
      Maternal and fetal outcomes of pregnancy in the setting of maternal cardiovascular disease, managed by multidiciplinary care in Manitoba
      Presented by: Dr. Sarah Gibbs, PGY2 - Internal Medicine
      Supervisor: Dr. Robin Ducas

      Original investigation - presentation (.mp4)
      The past decade of ACTH stimulation testing in Winnipeg
      Presented by: Dr. Umair Sajid, PGY3 – Internal Medicine
      Supervisor: Dr. Abdi Sokoro

      Research proposal - presentation (.mp4)
      Host gene variants associated with pneumonia in patients living with human immunodeficiency virus
      Presented by: Dr. Roy Hutchings, PGY2 - Internal Medicine
      Supervisor: Dr. Yoav Keynan


      9:45 a.m. - 10:00 a.m.

      GROUP 3

      Case report - presentation (.mp4)
      The endocrinologic associations of Birt-Hogg-Dube Syndrome: A review and case report
      Presented by: Dr. Alex Dalphy, PGY3 – Internal Medicine
      Supervisor: Dr. A. Arnaout

      Original investigation - presentation (.mp4)
      A retrospective analysis of the presentation, diagnosis, and initial management of adults presenting with meningitis to Health Sciences Center 2007-2020
      Presented by: Dr. Megan Sorokopud-Jones, PGY1 - Internal Medicine
      Supervisor: Dr. Ben Fultz

      Research proposal - presentation (.mp4)
      Promotion of econsult hematology service amongst primary care providers in Manitoba to reduce wait times and improve patient access
      Presented by: Dr. Farshad Ghasemi, PGY2 – Internal Medicine
      Supervisor: Dr. Vi Dao

      Original investigation - presentation (.mp4)
      The impact of virtual small group mediated ECG sessions on the competency of ECG interpretation among medical students
      Presented by: Dr. Tony Mao, PGY2 – Internal Medicine
      Supervisor: Dr. Malek Kass


      10:00 a.m. - 10:15 a.m.

      GROUP 4

      Research proposal - presentation (.mp4)
      Who is fit to drive home? A local review of physician adherence with mandatory reporting of medically unfit drivers
      Presented by: Dr. Carlo Navarro, PGY3 - Internal Medicine
      Supervisor: Dr. Jeff Wheeler & Dr. Ben Fultz

      Research proposal - presentation (.mp4)
      Prevalence of chronic spontaneous urticaria requiring omalizumab therapy in Manitoba’s First Nations and Non-First Nations population
      Presented by: Dr. Brian Lee, PGY2 - Internal Medicine
      Supervisor: Dr. Chrystyna Kalicinsky

      Research proposal - presentation (.mp4)
      Transfusion stewardship – alternatives to transfusion (for symptomatic and asymptomatic anemia) in women of child-bearing age (<45 years)
      Presented by: Dr. Izabella Supel, PGY2 – Internal Medicine
      Supervisor: Dr. Arjuna Ponnampalam

      Research proposal - presentation (.mp4)
      Determining the association between metabolic acidosis and osteoporosis in Manitoban CKD patients
      Presented by: Dr. Antonia Zhu, PGY2 – Internal Medicine
      Supervisor: Dr. Navdeep Tangri

      Original investigation - presentation (.mp4)
      Sleep disturbance and travel interruption prior to colonoscopy
      Presented by: Dr. Carmen Tse, PGY2 – Internal Medicine
      Supervisor: Dr. Harminder Singh

      Posters displayed in absentia   

      Original investigation - presentation (.mp4)
      Course and outcome of lupus nephritis in vulnerable patients
      Presented by: Dr. Matthew Thiessen, PGY2 - Internal Medicine
      Supervisor: Dr. Christine Peschken 

      Original investigation - presentation (.mp4)
      Severe distributive shock, neutrophillic dermatosis, and kounis syndrome (allergic coronary vasospasm) arising from azathioprine hypersensivity syndrome
      Presented by: Dr. Samuel Su, PGY3 - Internal Medicine
      Supervisor: Dr. Marcus Blouw         

      Original investigation - presentation (.mp4)
      Comparing response to intravenous iron infusion in Crohn’s disease and ulcerative colitis
      Presented by: Dr. Samuel Su, PGY3 - Internal Medicine
      Supervisor: Dr. Charles Bernstein

      Original investigation - presentation (.mp4)
      Adherence to guidelines for inpatient pharmacologic management of glucose levels using written compared to electronic orders
      Presented by: Dr. Jared Galloway, PGY3 - Internal Medicine
      Supervisor: Dr. Elizabeth Salamon

      Acknowledgments

      The Department of Internal Medicine gratefully acknowledges the participation of the following:

      Podium judges

      Dr. Shantanu Banerji
      Associate professor
      Section of Hematology and Oncology

      Dr. Liam O’Neil
      Assistant professor
      Section of Rheumatology

      Dr. Navdeep Tangri
      Associate professor
      Section of Nephrology

      Poster judges

      Dr. Christina Kim
      Assistant professor
      Section of Hematology and Oncology

      Dr. Asher Mendelson
      Assistant professor
      Section of Critical Care

      Dr. Barret Rush
      Assistant professor
      Section of Critical Care

      Best published paper judges

      Dr. Danielle Desautels
      Assistant professor
      Section of Hematology and Oncology

      Dr. Shuangbo Liu
      Assistant professor
      Section of Cardiology

      Community and outreach

      Faculty and staff

      Contact us

      Internal Medicine
      Room GC430, Health Sciences Centre
      820 Sherbrook Street
      University of Manitoba
      Winnipeg, MB R3A 1R9 Canada

      204-787-7772
      204-787-4826